FAQ

Frequently Asked Questions (FAQ):
Q1. What is a “Guerilla Biotech”?
Q2. Why is SRG a non-profit?
Q3. What is the focus of SRG?
Q4. What is “Open Access”?
Q5. How does SRG pay staff?
Q6. How does SRG rate as a charity?

A1.

A guerrilla biotech is a new type of development organization which is run lean and aggressive. They have limited brick-and-mortar infrastructure, utilizing outsourced for-hire lab services and materials. They use global Internet collaboration and can rapidly shift focus as new data appears. Guerrilla biotechs also leverage new materials and technology.
[back to top]

A2.

We at SciOpen Research Group have a personal connection to neurodegenerative diseases (NDDs). We are patients, family members, and/or close friends of people with NDDs. Because of our intense desire to see effective treatment for NDDs, we would rather maximize the resources put into research. Because we carry little overhead we can put nearly all of our money toward research. Our IRS Form 990s will be available to the public for review.
[back to top]

A3.

SciOpen Research Group’s initial focus is Amyotrophic Lateral Sclerosis (“Lou Gehrig’s Disease” or ALS). We believe research into this most heinous NDD can provide insight into other NDDs. We will make our findings and data available to Open Access medical journals.
[back to top]

A4.

From Wikipedia:
“Open access (OA) is the practice of providing unrestricted access via the Internet to peer-reviewed scholarly journal articles. OA is also increasingly being provided to theses, scholarly monographs and book chapters.”
[back to top]

A5.

Currently all of our staff are on a volunteer basis.
[back to top]

A6.

SRG has a Gold Rating from Guidestar. We are not eligible for a rating from Charity Navigator because our income is below $50,000.
[back to top]

Home of the world's first fully-functional guerrilla biotech